Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 68.14 M78.52 M — Research & development —— — Operating income 20.09 M39.34 M — Non-Operating Income, Total -20.58 M-10.46 M — Interest expense, net of interest capitalized 20.99 M10.84 M — Non-Operating Income, excl. Interest Expenses -41.5 M-10.14 M — Unusual income/expense -71 K-319 K — Pretax income -491 K28.88 M — Equity in earnings —— — Taxes -400 K4.4 M — Non-controlling/minority interest -337 K6.19 M — After tax other income/expense —— — Net income before discontinued operations 246 K18.29 M — Discontinued operations —— — Net income 246 K18.29 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 246 K19.63 M — Basic earnings per share (Basic EPS) —0.08 — Diluted earnings per share (Diluted EPS) —0.08 — Average basic shares outstanding —233.74 M — Diluted shares outstanding —233.9 M — EBITDA 46.49 M58.04 M — EBIT 20.09 M39.34 M — Cost of revenue 194.65 M247.51 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 26.4 M18.7 M —